Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in ABUS — Arbutus Biopharma Corp

CIK 1423053 MIAMI, FL
Back to ABUS Full portfolio

Position in ABUS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,942,540
-$1,104,581 QoQ
Shares Held
404,696
-40.2% QoQ
Ownership
0.205%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 175 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABUS Over Time

Shares Held

Position Value (USD)

Derivatives in ABUS

reported options exposure · as of Mar 31, 2026
CallValue
$145,800
CallShares
32,400
PutValue
$340,650
PutShares
75,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,839,618 across 436 Biotechnology names. ABUS ranks #205 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in ABUS

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,942,540 404,696
2026-03-31 $145,800 32,400
2026-03-31 $340,650 75,700
2026-03-31 $3,047,121 677,138
2025-12-31 $504,294 104,843
2025-12-31 $214,045 44,500
2025-09-30 $138,924 30,600
2025-09-30 $239,712 52,800
2025-09-30 $879,357 193,691
2025-06-30 $112,167 36,300
2025-06-30 $371,640 120,272
2025-06-30 $220,008 71,200
2025-03-31 $89,344 25,600
2025-03-31 $132,271 37,900
2025-03-31 $528,434 151,414
2024-12-31 $907,617 277,559
2024-12-31 $164,808 50,400
2024-12-31 $104,967 32,100
2024-09-30 $2,339,814 607,744
2024-09-30 $137,445 35,700
2024-09-30 $209,055 54,300
2024-06-30 $447,663 144,875
2024-06-30 $92,391 29,900
2024-06-30 $73,233 23,700
2024-03-31 $240,198 93,100
2024-03-31 $275,286 106,700
2024-03-31 $5,149,174 1,995,804
2023-12-31 $4,834,895 1,933,958
2023-12-31 $272,250 108,900
2023-12-31 $62,000 24,800
2023-09-30 $195,286 96,200
2023-09-30 $47,096 23,200
2023-09-30 $4,096,898 2,018,177
2023-06-30 $55,660 24,200
2023-06-30 $251,850 109,500
2023-06-30 $5,283,495 2,297,172
2023-03-31 $36,663 12,100
2023-03-31 $670,047 221,138
2023-03-31 $500,859 165,300
2022-12-31 $542,890 233,000
2022-12-31 $854,783 366,860
2022-12-31 $156,576 67,200
2022-09-30 $358,618 187,759
2022-09-30 $417,908 218,800
2022-09-30 $98,174 51,400
2022-06-30 $223,176 82,353
2022-06-30 $580,211 214,100
2022-06-30 $175,608 64,800
2022-03-31 $1,079,889 362,379
2022-03-31 $841,254 282,300

Report a Problem

Category
Description
Email (optional, for follow-up)